|  | Normoxia | CIH | ||||
---|---|---|---|---|---|---|---|
 |  |  | Puberty | Young adult** |  | Puberty | Young adult ** |
CA1 | Dopamine Transporter (DAT) | F | 91.27 ± 29.25 | 71.10 ± 18.23 ## | F | 104.42 ± 45.78 | 68.21 ± 31.17 ## |
M * | 84.76 ± 26.75 | 90.48 ± 25.92 # | M* | 92.81 ± 13.74 | 105.94 ± 20.84 # | ||
 |  | Puberty | Young adult |  | Puberty | Young adult | |
Monoamine Oxidase A (MAO-A) | F | 49.33 ± 13.76 | 52.03 ± 45.22 | F | 53.28 ± 14.38 | 43.49 ± 34.70 | |
M | 58.68 ± 38.36 | 54.45 ± 42.02 | M | 55.20 ± 25.98 | 43.79 ± 51.97 | ||
 |  | Puberty | Young adult** |  | Puberty | Young adult** | |
NMDA Receptor 2A (NR2A) | F | 75.11 ± 14.95 | 54.20 ± 19.37## | F | 76.22 ± 27.92 | 51.17 ± 22.55## | |
M | 73.82 ± 13.56 | 70.74 ± 24.76 | M | 64.43 ± 18.25 | 60.33 ± 25.83 |
 |  | Normoxia | CIH | ||||
---|---|---|---|---|---|---|---|
DG | Â | Â | Puberty | Young adult | Â | Puberty | Young adult |
Doublecortin (DC) | F | 99.27 ± 43.29 | 70.64 ± 45.29 | F | 79.45 ± 20.34 | 75.99 ± 46.04 | |
M | 94.30 ± 40.15 | 77.03 ± 31.08 | M | 103.62 ± 31.93 | 85.80 ± 23.07 | ||
 |  | Puberty | Young adult** |  | Puberty | Young adult** | |
Early Growth Response 1 (EGR-1) | F | 106.71 ± 34.31 | 57.76 ± 28.22## | F | 94.73 ± 19.25 | 49.51 ± 28.00## | |
M | 107.57 ± 26.71 | 59.96 ± 27.87## | M | 117.85 ± 10.63 | 76.40 ± 37.54## |